This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Allopurinol Teva 100mg Tablets PA0749/099/001 Teva Pharma B.V. | Allopurinol |
| Doxatan 4mg Tablets PA0126/202/003 Clonmel Healthcare Ltd | Doxazosin |
| Duphaston 10mg Film Coated Tablets PA2010/010/001 Mylan IRE Healthcare Limited | Dydrogesterone |
| Dupixent 300 mg Solution for injection EU/1/17/1229/006 Sanofi Winthrop Industrie | Dupilumab |
| Flixotide Evohaler 125mcg per metered dose pressurised inhalation, suspension 120 dose pack size PA1077/044/014 GlaxoSmithKline (Ireland) Limited | Fluticasone |
| Fucidin H 20mg/g + 10mg/g Cream PA0046/005/005 Leo Laboratories Limited | Hydrocortisone acetate & fusidic acid |
| Jext 300 micrograms solution for injection in pre-filled pen PA1255/006/002 ALK-Abello A/S | Adrenaline |
| Mestinon 60mg Tablets PA2010/052/001 Mylan IRE Healthcare Limited | Pyridostigmine |
| Norditropin FlexPro 5mg/1.5ml Solution for Injection PA0218/040/011 Novo Nordisk A/S | Somatropin |
| Polivy Powder for Concentrate for Solution for Infusion (140mg presentation) EU/1/19/1388/001 Roche Registration GmbH | Polatuzumab vedotin |
| Telmisartan Rowa 40mg Tablets PA0074/078/002 Rowa Pharmaceuticals Limited | Telmisartan |
| Tyvense 60mg Capsules PA23211/005/005 Takeda Pharmaceuticals International AG Ireland Branch | Lisdexamfetamine |
| Vitaros 3mg/g Cream PA1404/003/002 Recordati Ireland Limited | Alprostadil |
| Xatger 10mg Prolonged Release Tablets PA0577/079/002 McDermott Laboratories Ltd., T/A Gerard Laboratories | Alfuzosin |
| Zoledronic acid Mylan 4 mg/5ml Concentrate for solution for infusion PA0577/131/002 McDermott Laboratories Ltd., T/A Gerard Laboratories | Zoledronic acid |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| ARICEPT 10mg Film Coated Tablets PA0822/002/002 Pfizer Healthcare Ireland | Donepezil |
| Atomoxetine Accord 10 mg Hard Capsules (28 pack) PA2315/019/001 Accord Healthcare Ireland Ltd. | Atomoxetine |
| Betahistine dihydrochloride 16mg tablets PA2315/078/002 Accord Healthcare Ireland Ltd | Betahistine |
| Diflucan 150 mg hard capsules PA0822/211/002 Pfizer Healthcare Ireland | Fluconazole |
| Eplerenone Krka 25 mg film-coated tablets PA1347/078/001 KRKA, d.d., Novo mesto | Eplerenone |
| Etoricoxib Teva 90 mg film-coated tablets PA1986/002/003 Teva B.V. | Etoricoxib |
| Flucloxacillin 500 mg powder for solution for injection/infusion PA2059/069/001 Fresenius Kabi Deutschland GmbH | Flucloxacillin |
| Flucloxacillin 2000 mg powder for solution for injection/infusion PA2059/069/003 Fresenius Kabi Deutschland GmbH | Flucloxacillin |
| Lactulose Fresenius 670mg/ml oral solution PA0773/003/001 Fresenius Kabi Austria GmbH | Lactulose |
| Losartan/Hydrochlorothiazide Teva 50mg/12.5mg Film-Coated Tablets PA0749/026/001 Teva Pharma B.V. | Losartan & hydrochlorothiazide |
| Omeprazole Pinewood 20 mg gastro-resistant capsules, hard Pinewood Laboratories Ltd PA0281/152/001 | Omeprazole |
| Omeprazole Teva 20 mg gastro-resistant capsules, hard PA0749/160/002 Teva Pharma B.V | Omeprazole |
| Tadalafil 10mg Film-coated Tablets PA2315/071/002 Accord Healthcare Ireland Ltd | Tadalafil |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.